These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4542 related articles for article (PubMed ID: 18173375)

  • 1. PD-1 and its ligands in tolerance and immunity.
    Keir ME; Butte MJ; Freeman GJ; Sharpe AH
    Annu Rev Immunol; 2008; 26():677-704. PubMed ID: 18173375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The programmed death-1 ligand 1:B7-1 pathway restrains diabetogenic effector T cells in vivo.
    Paterson AM; Brown KE; Keir ME; Vanguri VK; Riella LV; Chandraker A; Sayegh MH; Blazar BR; Freeman GJ; Sharpe AH
    J Immunol; 2011 Aug; 187(3):1097-105. PubMed ID: 21697456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells.
    Goldberg MV; Maris CH; Hipkiss EL; Flies AS; Zhen L; Tuder RM; Grosso JF; Harris TJ; Getnet D; Whartenby KA; Brockstedt DG; Dubensky TW; Chen L; Pardoll DM; Drake CG
    Blood; 2007 Jul; 110(1):186-92. PubMed ID: 17392506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production.
    Brown JA; Dorfman DM; Ma FR; Sullivan EL; Munoz O; Wood CR; Greenfield EA; Freeman GJ
    J Immunol; 2003 Feb; 170(3):1257-66. PubMed ID: 12538684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutting Edge: Programmed death (PD) ligand-1/PD-1 interaction is required for CD8+ T cell tolerance to tissue antigens.
    Martin-Orozco N; Wang YH; Yagita H; Dong C
    J Immunol; 2006 Dec; 177(12):8291-5. PubMed ID: 17142723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The novel costimulatory programmed death ligand 1/B7.1 pathway is functional in inhibiting alloimmune responses in vivo.
    Yang J; Riella LV; Chock S; Liu T; Zhao X; Yuan X; Paterson AM; Watanabe T; Vanguri V; Yagita H; Azuma M; Blazar BR; Freeman GJ; Rodig SJ; Sharpe AH; Chandraker A; Sayegh MH
    J Immunol; 2011 Aug; 187(3):1113-9. PubMed ID: 21697455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
    Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
    J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The B7 family revisited.
    Greenwald RJ; Freeman GJ; Sharpe AH
    Annu Rev Immunol; 2005; 23():515-48. PubMed ID: 15771580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PD-1 on immature and PD-1 ligands on migratory human Langerhans cells regulate antigen-presenting cell activity.
    Peña-Cruz V; McDonough SM; Diaz-Griffero F; Crum CP; Carrasco RD; Freeman GJ
    J Invest Dermatol; 2010 Sep; 130(9):2222-30. PubMed ID: 20445553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of B7-H1 suppresses the development of chronic intestinal inflammation.
    Kanai T; Totsuka T; Uraushihara K; Makita S; Nakamura T; Koganei K; Fukushima T; Akiba H; Yagita H; Okumura K; Machida U; Iwai H; Azuma M; Chen L; Watanabe M
    J Immunol; 2003 Oct; 171(8):4156-63. PubMed ID: 14530338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of PD-L1 and PD-L2 in allergic diseases and asthma.
    Singh AK; Stock P; Akbari O
    Allergy; 2011 Feb; 66(2):155-62. PubMed ID: 20722638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PD-1/PD-L1 pathway in human pathology.
    Saresella M; Rainone V; Al-Daghri NM; Clerici M; Trabattoni D
    Curr Mol Med; 2012 Mar; 12(3):259-67. PubMed ID: 22300137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways.
    Fife BT; Bluestone JA
    Immunol Rev; 2008 Aug; 224():166-82. PubMed ID: 18759926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of programmed death 1 ligands by murine T cells and APC.
    Yamazaki T; Akiba H; Iwai H; Matsuda H; Aoki M; Tanno Y; Shin T; Tsuchiya H; Pardoll DM; Okumura K; Azuma M; Yagita H
    J Immunol; 2002 Nov; 169(10):5538-45. PubMed ID: 12421930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential binding properties of B7-H1 and B7-DC to programmed death-1.
    Youngnak P; Kozono Y; Kozono H; Iwai H; Otsuki N; Jin H; Omura K; Yagita H; Pardoll DM; Chen L; Azuma M
    Biochem Biophys Res Commun; 2003 Aug; 307(3):672-7. PubMed ID: 12893276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection.
    Sharpe AH; Wherry EJ; Ahmed R; Freeman GJ
    Nat Immunol; 2007 Mar; 8(3):239-45. PubMed ID: 17304234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation.
    Freeman GJ; Long AJ; Iwai Y; Bourque K; Chernova T; Nishimura H; Fitz LJ; Malenkovich N; Okazaki T; Byrne MC; Horton HF; Fouser L; Carter L; Ling V; Bowman MR; Carreno BM; Collins M; Wood CR; Honjo T
    J Exp Med; 2000 Oct; 192(7):1027-34. PubMed ID: 11015443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PD-1 pathway in tolerance and autoimmunity.
    Francisco LM; Sage PT; Sharpe AH
    Immunol Rev; 2010 Jul; 236():219-42. PubMed ID: 20636820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the PD-1 pathway in autoimmunity and peripheral tolerance.
    Fife BT; Pauken KE
    Ann N Y Acad Sci; 2011 Jan; 1217():45-59. PubMed ID: 21276005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue expression of PD-L1 mediates peripheral T cell tolerance.
    Keir ME; Liang SC; Guleria I; Latchman YE; Qipo A; Albacker LA; Koulmanda M; Freeman GJ; Sayegh MH; Sharpe AH
    J Exp Med; 2006 Apr; 203(4):883-95. PubMed ID: 16606670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 228.